Pharmacologic treatment of cognitive impairment after traumatic brain injury

Cognitive Neurorehabilitation

Volumn , Issue , 2015, Pages 321-333

  Whyte, John ^a,b  

^a MOSS REHABILITATION RESEARCH INSTITUTE   (United States)

^b THOMAS JEFFERSON UNIVERSITY   (United States)

Author keywords

Neurology and clinical neuroscience; Neuropsychology

Indexed keywords

EID: 84954304853     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1017/CBO9781316529898.023     Document Type: Chapter

References (54)

1. Bagne, C. A., & Lewis, R. F. (1992). Evaluating the effects of drugs on behavior and quality of life: an alternative strategy for clinical trials. Journal of Consulting and Clinical Psychology, 60, 225-239.
2. Blumbergs, P. C., Scott, G., Manavis, J., Wainwright, H., & Simpson, D. A. (1995). Topography of axonal injury as defined by amyloid precursor protein and the sector scoring method in mild and severe closed head injury. Journal of Neurotrauma, 12, 565-572.
3. Clausen, T., & Bullock, R. (2001). Medical treatment and neuroprotection in traumatic brain injury. Current Pharmacology Research, 7, 1517-1532.
4. Clifton, G. L., Grossman, R. G., Makela, M. E. et al. (1980). Neurological course and correlated computerized tomography findings after severe closed head injury. Journal of Neurosurgery, 52, 611-624.
5. Dikmen, S., McLean, A., & Temkin, N. (1986). Neuropsychological and psychosocial consequences of minor head injury. Journal of Neurology, Neurosurgery and Psychiatry, 49, 1227-1232.
6. Feeney, D. M., Gonzalez, A., & Law, W. A. (1982). Amphetamine, haloperidol, and experience interact to affect the rate of recovery after motor cortex injury. Science, 217, 855-857.
7. Fernandez-Duque, D., & Posner, M. I. (2001). Brain imaging of attentional networks in normal and pathological states. Journal of Clinical and Experimental Neuropsychology, 23, 74-93.
8. Giacino, J. T., Ashwal, S., Childs, N. et al. (2002). The minimally conscious state: definition and diagnostic criteria. Neurology, 58, 349-353.
9. Gottman, J. M., & Glass, G. V. (1978). Analysis of interrupted time-series experiments. In T. R. Kratochwill (Eds.), Single-subject Research Strategies for Evaluating Change (pp. 241-262). New York, NY: Academic Press.
10. Guyatt, G. H., & Jaeschke, R. (1990). N-of-1 randomized trials - where do we stand? Western Journal of Medicine, 152, 67-68.
11. Guyatt, G.H., Keller, J. L., Jaeschke, R. et al. (1990). Then-of-1 randomized controlled trial: clinical usefulness. Our threeyear experience. Annals of Internal Medicine, 112, 293-299.
12. Hersen, M., & Barlow, D. H. (1976). Single-case experimental designs: Strategies for studying behavior change. New York, NY: Pergamon Press.
13. Jacobs, A., Put, E., Ingels, M., Put, T., & Bossuyt, A. (1996). One-year follow-up of technetium-99m-HMPAO SPECT in mild head injury. Journal of Nuclear Medicine, 37, 1605-1609.
14. Kaelin, D. L., Cifu, D. X., & Matthies, B. (1996). Methylphenidate effect on attention deficit in the acutely braininjured adult. Archives of Physical Medicine and Rehabilitation, 77, 6-9.
15. Kent, M. A., Camfield, C. S., & Camfield, P. R. (1999). Double-blind methylphenidate trials: Practical, useful, and highly endorsed by families. Archives of Pediatric and Adolescent Medicine, 153, 1292-1296.
16. Kim, Y. H., Ko, M. H., Na, S. Y., Park, S. H., & Kim, K. W. (2006). Effects of single-dose methylphenidate on cognitive performance in patients with traumatic brain injury: a double-blind placebo-controlled study. Clinical Rehabilitation, 20, 24-30.
17. Kimberg, D. Y., Aguirre, G. K., Lease, J., & D’Esposito, M. (2001). Cortical effects of bromocriptine, a D-2 dopamine receptor agonist, in human subjects, revealed by fMRI. Human Brain Mapping, 12, 246-257.
18. Kinney, H. C., Korein, J., Panigrahy, A., Dikkes, P., & Goode, R. (1994). Neuropathological findings in the brain of Karen Ann Quinlan - the role of the thalamus in the persistent vegetative state. New England Journal of Medicine, 330, 1469-1475.
19. Larson, E. B. (1990). N-of-1 clinical trials. A technique for improving medical therapeutics. Western Journal of Medicine, 152, 52-56.
20. Lee, H., Kim, S. W., Kim, J. M. et al. (2005). Comparing effects of methylphenidate, sertraline and placebo on neuropsychiatric sequelae in patients with traumatic brain injury. Human Psychopharmacology, 20, 97-104.
21. Levin, H. S., Mattis, S., Ruff, R. M. et al. (1987). Neurobehavioral outcome following minor head injury: a three-center study. Journal of Neurosurgery, 66, 234-243.
22. Luciana, M., Depue, R. A., Arbisi, P., & Leon, A. (1992). Facilitation of working memory in humans by a D2 dopamine receptor agonist. Journal of Cognitive Neuroscience, 4, 58-68.
23. Mahon, J., Laupacis, A., Donner, A., & Wood, T. (1996). Randomised study of n of 1 trials versus standard practice. British Medical Journal, 312, 1069-1074.
24. McAllister, T. W. (1994). Mild traumatic brain injury and the postconcussive syndrome. In J. M. Silver, S. C. Yudofsky, & R. E. Hales (Eds.), Neuropsychiatry of Traumatic Brain Injury (pp. 357-392). Washington, DC: American Psychiatric Press, Inc.
25. McDowell, S., Whyte, J., & D’Esposito, M. (1998). Differential effect of a dopaminergic agonist on prefrontal function in traumatic brain injury patients. Brain, 121, 1155-1164.
26. Mehta, M. A., Owen, A. M., Sahakian, B. J. et al. (2000). Methylphenidate enhances working memory by modulating discrete frontal and parietal lobe regions in the human brain. Journal of Neuroscience, 20, RC65: 1-6.
27. Michelson, D., Adler, L., Spencer, T. et al. (2003). Atomoxetine in adults with ADHD: two randomized placebo-controlled studies. Biological Psychiatry, 53, 112-120.
28. Nikles, C. J., Clavarino, A. M., & Del Mar, C. B. (2005). Using n-of-1 trials as a clinical tool to improve prescribing. British Journal of General Practice, 55, 175-180.
29. Nissen, S. E. (2006). ADHD drugs and cardiovascular risk. New England Journal of Medicine, 354, 2296.
30. Notcutt, W., Price, M., Miller, R. et al. (2004). Initial experiences with medicinal extracts of cannabis for chronic pain: results from 34 "N of 1" studies. Anaesthesia, 59, 440-452.
31. Ottenbacher, K. J. (1986). Evaluating Clinical Change. Baltimore, MD: Williams & Wilkins.
32. Ottenbacher, K. J., & Hinderer, S. R. (2001). Evidencebased practice: methods to evaluate individual patient improvement. American Journal of Physical Medicine and Rehabilitation, 80, 786-796.
33. Pereira, J. A., Holbrook, A. M., Dolovich, L. et al. (2005). Are brand-name and generic warfarin interchangeable? Multiple n-of-1 randomized, crossover trials. Annals of Pharmacotherapy, 39, 1188-1193.
34. Robbins, T. W., & Everitt, B. J. (1995). Arousal systems and attention. In M. S. Gazzaniga (Eds.), The Cognitive Neurosciences (pp. 703-720). Cambridge, MA: MIT Press.
35. Sackett, D. L., Haynes, R. B., Guyatt, G. H., & Tugell, P. (1991). Clinical Epidemiology: A Basic Science for Clinical Medicine (2nd Edition). Boston, MA: Little Brown & Co.
36. Schluter, P. J., & Ware, R. S. (2005). Single patient (n-of-1) trials with binary treatment preference. Statistics in Medicine, 24, 2625-2636.
37. Siddall, O. M. (2005). Use of methylphenidate in traumatic brain injury. Annals of Pharmacotherapy, 39, 1309-1313.
38. Spencer, T., Biederman, J., Heiligenstein, J. et al. (2001). An open-label, dose-ranging study of atomexetine in children with attention deficit hyperactivity disorder. Journal of Child and Adolescent Psychopharmacology, 11, 251-265.
39. Stuss, D. T., Stethem, L. L., Hugenholtz, H. et al. (1989). Reaction time after head injury: fatigue, divided and focused attention, and consistency of performance. Journal of Neurology, Neurosurgery, and Psychiatry, 52, 742-748.
40. Stuss, D. T., Murphy, K. J., Binns, M. A., & Alexander, M. P. (2003). Staying on the job: the frontal lobes control individual performance variability. Brain, 126, 2363-2380.
41. Tales, A., Muir, J. L., Bayer, A., & Snowden, R. J. (2002). Spatial shifts in visual attention in normal ageing and dementia of the Alzheimer type. Neuropsychologia, 40, 2000-2012.
42. Walker-Batson, D., Smith, P., Curtis, S., Unwin, H., & Greenlee, R. (1995). Amphetamine paired with physical therapy accelerates motor recovery after stroke: Further evidence. Stroke, 26, 2254-2259.
43. Walker-Batson, D., Curtis, S., Natarajan, R. et al. (2001). A double-blind, placebo-controlled study of the use of amphetamine in the treatment of aphasia. Stroke, 32, 2093-2098.
44. Warden, D. L., Gordon, B., McAllister, T. W. (2006). Guidelines for the pharmacologic treatment of neurobehavioral sequelae of traumatic brain injury. Journal of Neurotrauma, 10, 1468-1501.
45. Whyte, J. (1997). Assessing medical rehabilitation practices: distinctive methodologic challenges. In M. J. Fuhrer (Ed.), The Promise of Outcomes Research, Vol.2 (pp. 43-59) Baltimore, MD: Brookes.
46. Whyte, J. (2002). Pharmacologic treatment of cognitive impairments: conceptual and methodological considerations. In P. Eslinger (Ed.), Neuropsychological Interventions (pp. 59-79). New York, NY: Guilford Publications.
47. Whyte, J., Hart, T., Schuster, K., et al. (1997). The effects of methylphenidate on attentional function after traumatic brain injury: a randomized, placebo-controlled trial. American Journal of Physical Medicine and Rehabilitation, 76, 440-450.
48. Whyte, J., DiPasquale, M., & Vaccaro, M. (1999). Assessment of command-following in minimally conscious brain injured patients. Archives of Physical Medicine and Rehabilitation, 80, 1-8.
49. Whyte, J., Hart, T., Laborde, A., & Rosenthal, M. (2004a). Rehabilitation issues in traumatic brain injury. In J. A. DeLisa, B. M. Gans, & W. L. Bockenek (Eds.), Rehabilitation Medicine: Principles and Practice (pp. 1677-1713). Philadelphia, PA: Lippincott.
50. Whyte, J., Hart, T., Vaccaro, M., et al. (2004b). The effects of methylphenidate on attention deficits after traumatic brain injury: a multi-dimensional randomized controlled trial. Journal of Physical Medicine and Rehabilitation, 83, 401-420.
51. Woodfield, R., Goodyear-Smith, F., & Arroll, B. (2005). N-of-1 trials of quinine efficacy in skeletalmuscle cramps of the leg. British Journal of General Practice, 55, 181-185.
52. World Health Organization International Classification of Functioning, Disability and Health. (www3.who.int/icf/icftemplate.cfm).
53. Zhang, L., Plotkin, R. C., Wang, G., Sandel, M. E., & Lee, S. (2004). Cholinergic augmentation with donepezil enhances recovery in short-term memory and sustained attention after traumatic brain injury. Archives of Physical Medicine and Rehabilitation, 85, 1050-1055.
54. Zucker, D. R., Schmid, C. H., McIntosh, M. W. et al. (1997). Combining single patient (N-of-1) trials to estimate population treatment effects and to evaluate individual patient responses to treatment. Journal of Clinical Epidemiology, 50, 401-410.